Pyridam Farma Tbk - Asset Resilience Ratio

Latest as of September 2025: 0.02%

Pyridam Farma Tbk (PYFA) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Pyridam Farma Tbk PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rp1.24 Billion

≈ $72.53K USD Cash + Short-term Investments

Total Assets

Rp6.92 Trillion

≈ $405.45 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2024)

This chart shows how Pyridam Farma Tbk's Asset Resilience Ratio has changed over time. See Pyridam Farma Tbk (PYFA) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Pyridam Farma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PYFA market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rp0.00	0%
Short-term Investments	Rp1.24 Billion	0.02%
Total Liquid Assets	Rp1.24 Billion	0.02%

Asset Resilience Insights

Limited Liquidity: Pyridam Farma Tbk maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pyridam Farma Tbk Industry Peers by Asset Resilience Ratio

Compare Pyridam Farma Tbk's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	1.28%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	Drug Manufacturers - Specialty & Generic	-0.89%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Xeris Pharmaceuticals Inc NASDAQ:XERS	Drug Manufacturers - Specialty & Generic	0.00%
Procter & Gamble Health Limited NSE:PGHL	Drug Manufacturers - Specialty & Generic	33.01%

Annual Asset Resilience Ratio for Pyridam Farma Tbk (2001–2024)

The table below shows the annual Asset Resilience Ratio data for Pyridam Farma Tbk.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.03%	Rp1.64 Billion ≈ $96.20K	Rp5.81 Trillion ≈ $340.51 Million	--
2023-12-31	0.00%	Rp0.00 ≈ $0.00	Rp1.52 Trillion ≈ $89.14 Million	--
2018-12-31	1.04%	Rp1.95 Billion ≈ $114.46K	Rp187.06 Billion ≈ $10.96 Million	+0.81pp
2017-12-31	0.24%	Rp379.65 Million ≈ $22.25K	Rp159.56 Billion ≈ $9.35 Million	-0.58pp
2016-12-31	0.82%	Rp1.37 Billion ≈ $79.99K	Rp167.06 Billion ≈ $9.79 Million	+0.74pp
2003-12-31	0.07%	Rp51.00 Million ≈ $2.99K	Rp68.27 Billion ≈ $4.00 Million	-5.47pp
2001-12-31	5.54%	Rp4.25 Billion ≈ $249.03K	Rp76.67 Billion ≈ $4.49 Million	--

pp = percentage points

About Pyridam Farma Tbk

JK:PYFA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$135.64 Million

Rp2.31 Trillion IDR

Market Cap Rank

#18119 Global

#280 in Indonesia

Share Price

Rp206.00

Change (1 day)

+6.19%

52-Week Range

Rp171.00 - Rp645.00

All Time High

Rp1480.00